Home Analyst Ratings Evercore ISI upgrades Zimmer Biomet Holdings Inc. to an Outperform rating...

Evercore ISI upgrades Zimmer Biomet Holdings Inc. [ZBH] to an Outperform rating with a $175 price target

‎Evercore ISI took its Zimmer Biomet Holdings Inc. [ZBH] rating to the equivalent of an Outperform ‎from ‎an In-line, and the price target to $175, in a research note dated January 04, 2021. That ‎figure ‎represents around a 13.56% premium from where the company’s shares closed on Thursday. ‎Meanwhile, ‎Needham had maintained its rating on ZBH to the earlier “Strong buy” rating, in a research ‎note ‎produced for clients December 18, 2020. In addition, there was a new coverage from Northland ‎Capital ‎on October 20, 2020. The research firm rated ZBH “a Market perform”.

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. ‎‎

Is Zimmer Biomet Holdings Inc. ‎‎[NYSE:ZBH] a Good Buy Right Now?

It should be noted that ‎ZBH technical indicators for short, ‎intermediate as well as long term progress have placed an overall ‎average of 100% as Buy. The average ‎signal changed from 100% Buy in the last week and compares ‎with 88% Buy in the past month. Data ‎from Zimmer Biomet Holdings Inc.’s Trend Spotter indicated that ‎the signals were Strongest. The stock ‎current average is 0.87 million shares in the past 20 days and the ‎short term average signal indicates a ‎‎100% Buy. In the last 50 days, the average trading volume was ‎‎1.11 million shares while the medium ‎term average advocated for 100% Buy. The average long-term ‎signal stands at 100% Buy and the 100-‎day average volume stands at 1.0 million shares.‎‎


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


ZBH Price Performance

On Wall Street, ‎Zimmer Biomet Holdings Inc. [NYSE:ZBH] finished ‎Thursday’s session up 1.23% at $154.09. The stock ‎went up to $154.48 at the same session while its ‎lowest single day price was $151.25. In the last five ‎days, it saw a rise of about 3.43%, Zimmer Biomet ‎Holdings Inc. shares gained by almost 2.95% since ‎the beginning of the year. However, the share price ‎has dropped to as low as -6.70% below its one ‎year high. On 11/09/20, the company shares recorded ‎‎$165.15, the highest single-day price it has got to ‎in the last 52-weeks and a 52-week low was seen on ‎‎03/18/20, the same year at $74.37. The company’s ‎shares have inclined by 3.28% in the past year. The ‎‎50-day SMA achieved is $145.90 while the 200-day ‎SMA is $131.20. Volume gained to 0.5 million from ‎‎0.43 million in the previous session.‎‎

ZBH Stock ‎Support And Resistance Levels

On the 24-hour scale, the immediate backing is ‎perceived around ‎‎152.07 level, and in case of violation of this particular level, it will cause more drop to ‎‎150.04 level. On ‎the upper level, 156.50 is still the key resistance. The stock may increase to the ‎subsequent resistance ‎at 155.30. The Relative Strength Index (RSI) pinned on the 14-day chart is 61.09, ‎implying a neutral ‎technical stance while the MACD stands at 3.67, meaning price will increase in the ‎next trading period. ‎Percent R indicator moved to 4.92%, implying bullish price movement. Stochastic ‎‎%K at 89.71% suggest ‎selling the stock.‎‎

What is the short interest in Zimmer Biomet Holdings Inc.?

Short interest in ‎the Zimmer ‎Biomet Holdings Inc. stock has plunged, decreasing by -0.17 million shares to total 2.19 ‎million shares ‎on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.02 million, data ‎from Yahoo ‎Finance shows. The increase of 7.76% suggests the stock saw some increased bearish ‎sentiment. The ‎stock’s days to cover (short ratio) moved to while the shorted shares account for just ‎‎1.06% of the ‎overall float for the stock.‎‎

Zimmer Biomet Holdings Inc.’s Biggest Shareholders: Who ‎Owns Zimmer Biomet Holdings Inc. ‎‎[ZBH]?

Filings by The Vanguard Group, Inc. showed that the ‎firm now holds a total of 14,919,624 ‎shares or roughly 7.20% of the outstanding ZBH shares. This means ‎their shares have reduced by -‎‎218,905 from the 14,919,624 the investor reportedly held in its prior 13-F ‎filing. With the conclusion of ‎the sale, BlackRock Fund Advisors updated stake is worth $1,643,664,016. ‎Details in the latest 13F filings ‎reveal that Massachusetts Financial Services disposed off their -1.55% ‎stake valued at $1,513,910,678 ‎while Capital Research & Management Co added theirs at ‎‎$1,462,396,130. During the last quarter, ‎Massachusetts Financial Services liquidated -159,496 of its ‎shares in Zimmer Biomet Holdings Inc. while ‎Capital Research & Management Co bought 1,150,763 ‎shares. The SSgA Funds Management, Inc.’s ‎holdings currently number 8,555,160 shares at ‎‎$1318264604.4. According to the firm’s last 13F report, T. ‎Rowe Price Associates, Inc. shares in the ‎company at filing stood at 6,524,014 shares, roughly ‎‎$972,860,968.‎‎

ZBH Earnings Forecast For The ‎Current Quarter

Zimmer Biomet Holdings Inc. [ZBH] is ‎expected to report weak earnings results ‎for the quarter ending on Dec 2020. Consensus estimates ‎give the company expected revenues of ‎‎$2.12B and an earnings per share of $2.1 for Dec 2020. ‎Looking further ahead, the company is expected ‎to report revenue of $1.92B at an EPS of $1.79 for ‎Mar 2021. The estimates represent downside of ‎‎15.20% and 40.46% in the company’s revenue and ‎earnings per share, respectively, on a year-on-year ‎basis.‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

ZBH Earnings Estimates For The ‎Current ‎Year

For the financial year, Zimmer Biomet Holdings Inc. [NYSE:ZBH] is expected to bring ‎in ‎revenue of $7.05B. The returns are nearly $-930.0 million lower than the company’s actual ‎revenue ‎recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 5.62, lower ‎than that of ‎FY19 by -$2.25. Estimates put this year’s earnings growth at -28.60%, 40.40% for the next, ‎and at an ‎annual 3.92% over the next 5-year period. As for sales, forecasts are for a decrease of -‎‎11.70% in the ‎current fiscal year and a further 15.20% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares

Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up...

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to...

Avalon Holdings Corporation (NYSE:AWX) stock surged in the current trading session; here’s why

At last check, in the current trading session, AWX stock surged by 22.58% to $5.08. AWX stock previously closed the session at $4.14. The...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.